Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles

Wen Jiang, Yuhui Huang, Yi An, Y S Betty Kim

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Restoration of dysfunctional tumor vasculature can reestablish the pressure gradient between intravascular and interstitial space that is essential for transporting nanomedicines into solid tumors. Morphologic and functional normalization of tumor vessels improves tissue perfusion to facilitate intratumoral nanoparticle delivery. However, this remodeling process also reduces tumor vessel permeability, which can impair nanoparticle transport. Although nanoparticles sized below 10 nm maximally benefited from tumor vessel normalization therapy for enhanced nanomedicine delivery, the small particle size severely limits its applicability. Here, we show that intermediate-sized nanoparticles (20-40 nm) can also benefit from tumor vasculature remodeling. We demonstrate that a window of opportunity exists for a two-stage transport strategy of different nanoparticle sizes. Overall, tumor vessel remodeling enhances the transvascular delivery of intermediate-size nanoparticles of up to 40 nm. Once within the tumor matrix, however, smaller nanoparticles experience a significantly lesser degree of diffusional hindrance, resulting in a more homogeneous distribution within the tumor interstitium. These findings suggest that antiangiogenic therapy and nanoparticle design can be combined in a multistage fashion, with two sets of size-inclusion criteria, to achieve optimal nanomedicine delivery into solid tumors.

Original languageEnglish (US)
Pages (from-to)8689-8696
Number of pages8
JournalACS Nano
Volume9
Issue number9
DOIs
StatePublished - Sep 22 2015

Fingerprint

Tumors
delivery
tumors
Nanoparticles
nanoparticles
Medical nanotechnology
vessels
therapy
Pressure gradient
pressure gradients
restoration
Restoration
permeability
interstitials
Particle size
inclusions
Tissue
matrices

Keywords

  • antiangiogenic therapy
  • nanomedicine
  • tumor delivery
  • tumor targeting

ASJC Scopus subject areas

  • Materials Science(all)
  • Engineering(all)
  • Physics and Astronomy(all)

Cite this

Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles. / Jiang, Wen; Huang, Yuhui; An, Yi; Kim, Y S Betty.

In: ACS Nano, Vol. 9, No. 9, 22.09.2015, p. 8689-8696.

Research output: Contribution to journalArticle

Jiang, Wen ; Huang, Yuhui ; An, Yi ; Kim, Y S Betty. / Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles. In: ACS Nano. 2015 ; Vol. 9, No. 9. pp. 8689-8696.
@article{d53c1f3ff23e41449368efbc4c570f67,
title = "Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles",
abstract = "Restoration of dysfunctional tumor vasculature can reestablish the pressure gradient between intravascular and interstitial space that is essential for transporting nanomedicines into solid tumors. Morphologic and functional normalization of tumor vessels improves tissue perfusion to facilitate intratumoral nanoparticle delivery. However, this remodeling process also reduces tumor vessel permeability, which can impair nanoparticle transport. Although nanoparticles sized below 10 nm maximally benefited from tumor vessel normalization therapy for enhanced nanomedicine delivery, the small particle size severely limits its applicability. Here, we show that intermediate-sized nanoparticles (20-40 nm) can also benefit from tumor vasculature remodeling. We demonstrate that a window of opportunity exists for a two-stage transport strategy of different nanoparticle sizes. Overall, tumor vessel remodeling enhances the transvascular delivery of intermediate-size nanoparticles of up to 40 nm. Once within the tumor matrix, however, smaller nanoparticles experience a significantly lesser degree of diffusional hindrance, resulting in a more homogeneous distribution within the tumor interstitium. These findings suggest that antiangiogenic therapy and nanoparticle design can be combined in a multistage fashion, with two sets of size-inclusion criteria, to achieve optimal nanomedicine delivery into solid tumors.",
keywords = "antiangiogenic therapy, nanomedicine, tumor delivery, tumor targeting",
author = "Wen Jiang and Yuhui Huang and Yi An and Kim, {Y S Betty}",
year = "2015",
month = "9",
day = "22",
doi = "10.1021/acsnano.5b02028",
language = "English (US)",
volume = "9",
pages = "8689--8696",
journal = "ACS Nano",
issn = "1936-0851",
publisher = "American Chemical Society",
number = "9",

}

TY - JOUR

T1 - Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles

AU - Jiang, Wen

AU - Huang, Yuhui

AU - An, Yi

AU - Kim, Y S Betty

PY - 2015/9/22

Y1 - 2015/9/22

N2 - Restoration of dysfunctional tumor vasculature can reestablish the pressure gradient between intravascular and interstitial space that is essential for transporting nanomedicines into solid tumors. Morphologic and functional normalization of tumor vessels improves tissue perfusion to facilitate intratumoral nanoparticle delivery. However, this remodeling process also reduces tumor vessel permeability, which can impair nanoparticle transport. Although nanoparticles sized below 10 nm maximally benefited from tumor vessel normalization therapy for enhanced nanomedicine delivery, the small particle size severely limits its applicability. Here, we show that intermediate-sized nanoparticles (20-40 nm) can also benefit from tumor vasculature remodeling. We demonstrate that a window of opportunity exists for a two-stage transport strategy of different nanoparticle sizes. Overall, tumor vessel remodeling enhances the transvascular delivery of intermediate-size nanoparticles of up to 40 nm. Once within the tumor matrix, however, smaller nanoparticles experience a significantly lesser degree of diffusional hindrance, resulting in a more homogeneous distribution within the tumor interstitium. These findings suggest that antiangiogenic therapy and nanoparticle design can be combined in a multistage fashion, with two sets of size-inclusion criteria, to achieve optimal nanomedicine delivery into solid tumors.

AB - Restoration of dysfunctional tumor vasculature can reestablish the pressure gradient between intravascular and interstitial space that is essential for transporting nanomedicines into solid tumors. Morphologic and functional normalization of tumor vessels improves tissue perfusion to facilitate intratumoral nanoparticle delivery. However, this remodeling process also reduces tumor vessel permeability, which can impair nanoparticle transport. Although nanoparticles sized below 10 nm maximally benefited from tumor vessel normalization therapy for enhanced nanomedicine delivery, the small particle size severely limits its applicability. Here, we show that intermediate-sized nanoparticles (20-40 nm) can also benefit from tumor vasculature remodeling. We demonstrate that a window of opportunity exists for a two-stage transport strategy of different nanoparticle sizes. Overall, tumor vessel remodeling enhances the transvascular delivery of intermediate-size nanoparticles of up to 40 nm. Once within the tumor matrix, however, smaller nanoparticles experience a significantly lesser degree of diffusional hindrance, resulting in a more homogeneous distribution within the tumor interstitium. These findings suggest that antiangiogenic therapy and nanoparticle design can be combined in a multistage fashion, with two sets of size-inclusion criteria, to achieve optimal nanomedicine delivery into solid tumors.

KW - antiangiogenic therapy

KW - nanomedicine

KW - tumor delivery

KW - tumor targeting

UR - http://www.scopus.com/inward/record.url?scp=84942265260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942265260&partnerID=8YFLogxK

U2 - 10.1021/acsnano.5b02028

DO - 10.1021/acsnano.5b02028

M3 - Article

VL - 9

SP - 8689

EP - 8696

JO - ACS Nano

JF - ACS Nano

SN - 1936-0851

IS - 9

ER -